Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Apr 26;10(5):671.
doi: 10.3390/antiox10050671.

Current Perspective of Hydrogen Sulfide as a Novel Gaseous Modulator of Oxidative Stress in Glaucoma

Affiliations
Review

Current Perspective of Hydrogen Sulfide as a Novel Gaseous Modulator of Oxidative Stress in Glaucoma

Yuan Feng et al. Antioxidants (Basel). .

Abstract

Glaucoma is a group of diseases characterized by the progressive loss of retinal ganglion cells and their axons. Elevated intraocular pressure (IOP) is the main clinical manifestation of glaucoma. Despite being in the focus of the studies for decades, the characteristic and the exact pathology of neurodegeneration in glaucoma remains unclear. Oxidative stress is believed to be one of the main risk factors in neurodegeneration, especially its damage to the retinal ganglion cells. Hydrogen sulfide (H2S), the recently recognized gas signaling molecule, plays a pivotal role in the nervous system, vascular system, and immune system. It has also shown properties in regulating oxidative stress through different pathways in vivo. In this review, we summarize the distribution and the properties of H2S within the eye with an emphasis on its role in modulating oxidative stress in glaucoma.

Keywords: glaucoma; hydrogen sulfide; neurodegeneration; oxidative stress.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Endogenous H2S is produced through two main pathways, the non-enzymatic pathway and the enzymatic pathway. The non-enzymatic pathway is produced in erythrocytes via the glucose oxidation pathway. The enzymatic pathway promotes the production of H2S from cysteine with four common enzymes (cystathionine-β-lyase (CBS), cystathionine-γ-synthase (CSE), 3-mercapto-methylthio pyruvate aminotransferase (3MST), and cysteine aminotransferase (CAT)). These enzymes are distributed in various tissues of the body.
Figure 2
Figure 2
The anti-oxidative properties of H2S in glaucoma. The effect of H2S on glaucoma is mainly reflected in three aspects. (1) By regulating the autonomic nerves and reducing the release of sympathetic nerves, it reduces the production of aqueous humor (AH) and promotes the flow of AH to lowering intraocular pressure (IOP). (2) Through the relaxation of vascular smooth muscles, stabilize intraocular perfusion and reduce ischemia-reperfusion injury. (3) By regulating iron homeostasis, regulating mitochondrial function, and reducing the toxicity of glutamate, it reduces the generation of ROS to prevent nerve degenerative changes.
Figure 3
Figure 3
H2S promotes the synthesis of glutathione in cells through three pathways. (1) H2S suppresses the extracellular competition between glutamate and cystine, therefore promotes cystine (the substrate of glutathione (GSH) synthesis) entering the cells. (2) H2S promotes the production of a variety of glutathione synthase and increases the concentration of GSH in the cell. (3) H2S indirectly promotes the synthesis of GSH through the Nrf2-dependent pathway.

Similar articles

Cited by

  • Design, Synthesis and Evaluation of Novel Molecular Hybrids between Antiglaucoma Drugs and H2S Donors.
    Sparaco R, Citi V, Magli E, Martelli A, Piragine E, Calderone V, Andreozzi G, Perissutti E, Frecentese F, Santagada V, Caliendo G, Severino B, Corvino A, Fiorino F. Sparaco R, et al. Int J Mol Sci. 2022 Nov 9;23(22):13804. doi: 10.3390/ijms232213804. Int J Mol Sci. 2022. PMID: 36430281 Free PMC article.
  • Consensus Recommendation for Mouse Models of Ocular Hypertension to Study Aqueous Humor Outflow and Its Mechanisms.
    McDowell CM, Kizhatil K, Elliott MH, Overby DR, van Batenburg-Sherwood J, Millar JC, Kuehn MH, Zode G, Acott TS, Anderson MG, Bhattacharya SK, Bertrand JA, Borras T, Bovenkamp DE, Cheng L, Danias J, De Ieso ML, Du Y, Faralli JA, Fuchshofer R, Ganapathy PS, Gong H, Herberg S, Hernandez H, Humphries P, John SWM, Kaufman PL, Keller KE, Kelley MJ, Kelly RA, Krizaj D, Kumar A, Leonard BC, Lieberman RL, Liton P, Liu Y, Liu KC, Lopez NN, Mao W, Mavlyutov T, McDonnell F, McLellan GJ, Mzyk P, Nartey A, Pasquale LR, Patel GC, Pattabiraman PP, Peters DM, Raghunathan V, Rao PV, Rayana N, Raychaudhuri U, Reina-Torres E, Ren R, Rhee D, Chowdhury UR, Samples JR, Samples EG, Sharif N, Schuman JS, Sheffield VC, Stevenson CH, Soundararajan A, Subramanian P, Sugali CK, Sun Y, Toris CB, Torrejon KY, Vahabikashi A, Vranka JA, Wang T, Willoughby CE, Xin C, Yun H, Zhang HF, Fautsch MP, Tamm ER, Clark AF, Ethier CR, Stamer WD. McDowell CM, et al. Invest Ophthalmol Vis Sci. 2022 Feb 1;63(2):12. doi: 10.1167/iovs.63.2.12. Invest Ophthalmol Vis Sci. 2022. PMID: 35129590 Free PMC article. Review.

References

    1. Casson R.J., Chidlow G., Wood J.P.M., Crowston J.G., Goldberg I. Definition of glaucoma: Clinical and experimental concepts. Clin. Exp. Ophthalmol. 2012;40:341–349. doi: 10.1111/j.1442-9071.2012.02773.x. - DOI - PubMed
    1. Chang E.E., Goldberg J.L. Glaucoma 2.0: Neuroprotection, Neuroregeneration, Neuroenhancement. Ophthalmology. 2012;119:979–986. doi: 10.1016/j.ophtha.2011.11.003. - DOI - PMC - PubMed
    1. Huang S., Huang P., Liu X., Lin Z., Wang J., Xu S., Guo L., Leung C.K.-S., Zhong Y. Relevant variations and neuroprotecive effect of hydrogen sulfide in a rat glaucoma model. Neuroscience. 2017;341:27–41. doi: 10.1016/j.neuroscience.2016.11.019. - DOI - PubMed
    1. Križaj D., Ryskamp D.A., Tian N., Tezel G., Mitchell C.H., Slepak V.Z., Shestopalov V.I. From Mechanosensitivity to Inflammatory Responses: New Players in the Pathology of Glaucoma. Curr. Eye Res. 2014;39:105–119. doi: 10.3109/02713683.2013.836541. - DOI - PMC - PubMed
    1. Biermann J., Lagreze W.A., Schallner N., Schwer C.I., Goebel U. Inhalative preconditioning with hydrogen sulfide attenuated apoptosis after retinal ischemia/reperfusion injury. Mol. Vis. 2011;17:1275–1286. - PMC - PubMed

LinkOut - more resources